ECM
BSX icon

ExodusPoint Capital Management’s Boston Scientific BSX Stock Holding History

ExodusPoint Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.5M Buy
311,363
+138,963
+81% +$11.1M 0.16% 107
2025
Q4 		$16.4M Sell
172,400
-30,250
-15% -$2.97M 0.13% 136
2025
Q3 		$19.8M Sell
202,650
-553,217
-73% -$57.3M 0.2% 91
2025
Q2 		$81.2M Buy
755,867
+194,602
+35% +$19.7M 0.71% 16
2025
Q1 		$56.6M Buy
561,265
+257,901
+85% +$26M 0.56% 21
2024
Q4 		$27.1M Sell
303,364
-700,160
-70% -$61.6M 0.19% 87
2024
Q3 		$84.1M Buy
1,003,524
+323,831
+48% +$25.5M 0.51% 24
2024
Q2 		$52.3M Buy
679,693
+451,884
+198% +$33.1M 0.36% 35
2024
Q1 		$15.6M Buy
+227,809
New +$14.6M 0.12% 136
2023
Q3 		– Sell
-362,484
Closed -$19.6M – 1725
2023
Q2 		$19.6M Buy
362,484
+201,709
+125% +$10.5M 0.16% 112
2023
Q1 		$8.04M Buy
+160,775
New +$7.58M 0.07% 353
2022
Q3 		– Sell
-92,295
Closed -$3.44M – 1897
2022
Q2 		$3.44M Sell
92,295
-88,212
-49% -$3.59M 0.04% 550
2022
Q1 		$8M Buy
180,507
+89,134
+98% +$3.86M 0.1% 247
2021
Q4 		$3.88M Sell
91,373
-26,753
-23% -$1.12M 0.04% 524
2021
Q3 		$5.13M Buy
118,126
+56,649
+92% +$2.51M 0.07% 392
2021
Q2 		$2.63M Sell
61,477
-72,020
-54% -$3.03M 0.03% 558
2021
Q1 		$5.16M Sell
133,497
-110,976
-45% -$4.2M 0.08% 258
2020
Q4 		$8.79M Buy
244,473
+227,754
+1,362% +$8.21M 0.09% 143
2020
Q3 		$639K Sell
16,719
-121,691
-88% -$4.69M 0.01% 887
2020
Q2 		$4.86M Buy
138,410
+19,304
+16% +$695K 0.13% 166
2020
Q1 		$3.89M Buy
119,106
+113,148
+1,899% +$4.42M 0.21% 81
2019
Q4 		$269K Sell
5,958
-15,434
-72% -$646K 0.01% 1206
2019
Q3 		$870K Buy
+21,392
New +$906K 0.03% 430

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ExodusPoint Capital Management's BSX Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Boston Scientific (BSX) stake by 81% in Q1 2026, buying an estimated $11.1M and bringing the position to 311,363 shares worth $19.5M. The position accounts for 0.16% of the portfolio, ranked #107.

ExodusPoint Capital Management first reported a position in BSX in Q3 2019 and has held it in 23 quarters since. The position peaked at $84.1M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • ExodusPoint Capital Management held 311,363 shares of Boston Scientific worth $19.5M as of Q1 2026.
  • ExodusPoint Capital Management bought 138,963 Boston Scientific shares in Q1 2026, an estimated $11.1M.
  • Boston Scientific made up 0.16% of ExodusPoint Capital Management's portfolio in Q1 2026, its #107 holding.
  • ExodusPoint Capital Management first reported a position in Boston Scientific in Q3 2019 and has held it in 23 quarters since.
  • ExodusPoint Capital Management's Boston Scientific position peaked at $84.1M in Q3 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.